Loading...
Please wait, while we are loading the content...
CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Fiorillo, M. T. Maragno, M. Butler, Rachel K. Dupuis, Maria Luisa Sorrentino, Rosa |
| Copyright Year | 2000 |
| Abstract | HLA-B27 is highly associated with ankylosing spondylitis (AS), but the mechanism is unknown. Among the HLA-B27 alleles, B*2709, which differs by one amino acid from the susceptible B*2705, is not associated with the disease. Here, we analyze the reactivity, in patients with AS and in healthy controls carrying the B*2709 or B*2705 alleles, to an EBV epitope derived from LMP2 (236-244) and to a sequence-related self-peptide from vasoactive intestinal peptide receptor 1 (VIP1R 400-408). We found that both B*2705(+) and B*2709(+) subjects possess LMP2 236-244-specific, HLA-B27-restricted T cells, whereas only the B*2705(+) individuals respond significantly to VIP1R 400-408. These results prompted us to compare, by IFN-gamma ELISPOT analysis, the T-cell response to VIP1R 400-408 in patients with AS versus B*2705 healthy controls. The data show that VIP1R 400-408-specific reactivity is a major feature of the patients with AS. These findings show, for the first time to our knowledge, a widespread reactivity in patients with AS against a self-epitope that exhibits some features of a putative "arthritogenic" peptide. |
| Starting Page | 47 |
| Ending Page | 53 |
| Page Count | 7 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://dm5migu4zj3pb.cloudfront.net/manuscripts/9000/9295/JCI0009295.pdf |
| PubMed reference number | 10880047v1 |
| Volume Number | 106 |
| Issue Number | 1 |
| Journal | The Journal of clinical investigation |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Alleles Amino Acids Ankylosing spondylitis Cellular Phone Enzyme-Linked Immunospot Assay Epstein-Barr Virus Exhibits as Topic HLA Antigens HLA-B27 Antigen Histocompatibility Antigens Class II Interferon Type II PSMB9 gene Patients Peptide Receptor Receptors, Vasoactive Intestinal Peptide T-Lymphocyte VIPR1 protein, human |
| Content Type | Text |
| Resource Type | Article |